• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects.

作者信息

Zhang Y A, Reviriego J, Lou Y Q, Sjöqvist F, Bertilsson L

机构信息

Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.

出版信息

Clin Pharmacol Ther. 1990 Nov;48(5):496-502. doi: 10.1038/clpt.1990.185.

DOI:10.1038/clpt.1990.185
PMID:2225709
Abstract

A single oral 5 mg dose of diazepam was given to 16 healthy native Chinese Han volunteers. Eight volunteers were extensive metabolizers of S-mephenytoin, and eight were poor metabolizers of S-mephenytoin. Plasma levels of diazepam and its demethyl metabolite were determined by HPLC in blood samples drawn during 4 weeks. There was no difference in diazepam disposition between the two phenotypes. However, the plasma half-life of demethyldiazepam was longer in poor metabolizers than in extensive metabolizers of mephenytoin (mean +/- SD: 161 +/- 37 and 116 +/- 29 hours, respectively; p less than 0.02). The plasma concentrations of demethyldiazepam at 7, 14, and 21 days after intake of diazepam were significantly higher in poor metabolizers than in extensive metabolizers. We compared the pharmacokinetic parameters of diazepam in Chinese subjects with our previously reported data from white subjects. The mean plasma half-life values of diazepam in Chinese extensive metabolizers (85.1 hours) and poor metabolizers (88.3 hours) were very similar to those in white subjects who were poor metabolizers (88.3 hours), and more than twice those in white subjects who were extensive metabolizers (40.8 hours). In parallel, the mean clearance of diazepam in Chinese subjects (independent of phenotype) was similar to that in white subjects who were poor metabolizers, but half that in white subjects who were extensive metabolizers. Chinese subjects had a slightly larger volume of distribution of diazepam than white subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects.
Clin Pharmacol Ther. 1990 Nov;48(5):496-502. doi: 10.1038/clpt.1990.185.
2
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.韩国人群中S-美芬妥因羟化缺乏症的发生率及地西泮药代动力学的表型间差异。
Clin Pharmacol Ther. 1992 Aug;52(2):160-9. doi: 10.1038/clpt.1992.125.
3
Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.遗传因素在地西泮代谢调节中的重要性:与S-美芬妥因而非异喹胍羟化表型的关系。
Clin Pharmacol Ther. 1989 Apr;45(4):348-55. doi: 10.1038/clpt.1989.40.
4
Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.新型质子泵抑制剂E3810与奥美拉唑在S-美芬妥因4'-羟化代谢广泛者和代谢不良者中与地西泮相互作用潜力的比较。
Clin Pharmacol Ther. 1995 Aug;58(2):155-64. doi: 10.1016/0009-9236(95)90193-0.
5
Interethnic difference in omeprazole's inhibition of diazepam metabolism.
Clin Pharmacol Ther. 1995 Jul;58(1):62-72. doi: 10.1016/0009-9236(95)90073-X.
6
The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype.在中国受试者中,地西泮的消除取决于美芬妥因氧化表型。
Br J Clin Pharmacol. 1996 Oct;42(4):471-4. doi: 10.1046/j.1365-2125.1996.42712.x.
7
Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects.
Pharmacogenetics. 1992 Feb;2(1):25-31. doi: 10.1097/00008571-199202000-00005.
8
Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin.中国本土人群与瑞典人群在异喹胍和S-美芬妥因多态性羟化方面存在显著差异。
Clin Pharmacol Ther. 1992 Apr;51(4):388-97. doi: 10.1038/clpt.1992.38.
9
Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?为什么地西泮代谢和多态性S-美芬妥因羟化在白种人和韩国人群中相互关联,而在中国人群中却没有这种关联?
Clin Pharmacol Ther. 1993 May;53(5):608-10. doi: 10.1038/clpt.1993.77.
10
Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.S-美芬妥因4'-羟化代谢能力差者的肝脏中缺乏低Km地西泮N-脱甲基酶。
Pharmacogenetics. 1994 Dec;4(6):323-31. doi: 10.1097/00008571-199412000-00005.

引用本文的文献

1
Pharmacogenetics of alcohol addiction: current perspectives.酒精成瘾的药物遗传学:当前观点
Appl Clin Genet. 2019 Jul 11;12:131-140. doi: 10.2147/TACG.S206745. eCollection 2019.
2
Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites.CYP2C19和CYP3A5基因多态性对西洛他唑及其活性代谢产物药代动力学的影响。
Eur J Clin Pharmacol. 2018 Nov;74(11):1417-1426. doi: 10.1007/s00228-018-2522-5. Epub 2018 Jul 24.
3
Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.
健康中国受试者和欧洲受试者中CYP2C9、CYP2C19和CYP2D6底物的药代动力学
Eur J Clin Pharmacol. 2018 Mar;74(3):285-296. doi: 10.1007/s00228-017-2375-3. Epub 2017 Nov 27.
4
Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer.CYP2C19基因多态性对胰腺癌患者中奈非那韦药代动力学的影响。
Br J Clin Pharmacol. 2015 Aug;80(2):267-75. doi: 10.1111/bcp.12620. Epub 2015 Jun 11.
5
Clinical significance of the cytochrome P450 2C19 genetic polymorphism.细胞色素P450 2C19基因多态性的临床意义
Clin Pharmacokinet. 2002;41(12):913-58. doi: 10.2165/00003088-200241120-00002.
6
Polymorphic cytochromes P450 and drugs used in psychiatry.多态性细胞色素P450与精神科用药
Cell Mol Neurobiol. 1999 Jun;19(3):325-54. doi: 10.1023/a:1006945715127.
7
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.多态性药物氧化的地理/种族差异。细胞色素P450(CYP)2D6和2C19的现有知识状况。
Clin Pharmacokinet. 1995 Sep;29(3):192-209. doi: 10.2165/00003088-199529030-00005.
8
Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.
Eur J Clin Pharmacol. 1993;44(6):593-5. doi: 10.1007/BF02440867.
9
Genetically determined adverse drug reactions involving metabolism.涉及代谢的基因决定的药物不良反应。
Drug Saf. 1993 Jul;9(1):60-77. doi: 10.2165/00002018-199309010-00006.
10
Clinical trials and transethnic pharmacology.临床试验与跨种族药理学。
Drug Saf. 1994 Nov;11(5):378-91. doi: 10.2165/00002018-199411050-00005.